SCHEMBL8894520

SCHEMBL8894520

CC(C)C[C@H](O)[C@H](O)CC(C(N)=O)C(Cc1csc(N)n1)C(N)=O

nearest known ligand 0.42

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
GABRA5 P31644 1/20 0.42
GABRB2 P47870 1/20 0.42
HSD17B10 Q99714 1/20 0.42
REN P00797 7/20 0.36
ALDH1A1 P00352 3/20 0.35
NPC1 O15118 3/20 0.35
RAB9A P51151 3/20 0.35
MEN1 O00255 1/20 0.35
MAPT P10636 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 4/20 0.33
CTSD P07339 1/20 0.32
AOC3 Q16853 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8897017 0.73 FDPS (0.41) RENALDH1A1
SCHEMBL3615864 0.72 GABRA5 (0.48) GABRA5GABRB2HSD17B10ALDH1A1NPC1
SCHEMBL8254599 0.70 GABRA5 (0.47) GABRA5GABRB2HSD17B10RENALDH1A1
SCHEMBL5869739 0.70 GABRA5 (0.47) GABRA5GABRB2HSD17B10RENALDH1A1
SCHEMBL9864531 0.69 HSD17B10 (0.56) GABRA5GABRB2HSD17B10ALDH1A1NPC1
SCHEMBL27391773 0.68 GABRA5 (0.50) GABRA5GABRB2HSD17B10ALDH1A1NPC1
SCHEMBL8955092 0.65 HSD17B10 (0.59) GABRA5GABRB2HSD17B10ALDH1A1RAB9A
SCHEMBL30583244 0.65 GABRA5 (0.46) GABRA5GABRB2HSD17B10ALDH1A1NPC1
SCHEMBL28694718 0.65 HSD17B10 (0.59) GABRA5GABRB2HSD17B10ALDH1A1RAB9A
SCHEMBL1081994 0.65 GABRA5 (0.54) GABRA5GABRB2HSD17B10ALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5693619-A ENZYME INHIBITORS; ADMINISTERED TO TREAT CONGESTIVE HEART FAILURE AND HYPERTENSION BOEHRINGER INGELHEIM (CANADA), LTD. (CA) 1997-12-02 US claimed